Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1311-1316
Published online before print February 25, 2002, doi: 10.1161/hc1102.105565
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/11/1311    most recent
hc1102.105565v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oh, J.-Y.
Right arrow Articles by Wedick, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, J.-Y.
Right arrow Articles by Wedick, N. M.
Related Collections
Right arrow Epidemiology

(Circulation. 2002;105:1311.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Sex Differences in the Association Between Proinsulin and Intact Insulin With Coronary Heart Disease in Nondiabetic Older Adults

The Rancho Bernardo Study

Jee-Young Oh, MD; Elizabeth Barrett-Connor, MD; Nicole M. Wedick, MS

From the Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego.

Correspondence to Dr Elizabeth Barrett-Connor, Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0607. E-mail ebarrettconnor{at}ucsd.edu

Background Insulin or insulin resistance is considered a coronary heart disease (CHD) risk factor, but proinsulin may have a stronger association with CHD than insulin. The role of sex differences in this association is unclear. We examined the cross-sectional association of proinsulin and insulin with CHD in older men and women without diabetes.

Methods and Results A cross-sectional study of community-dwelling men (n=554) and women (n=902), 50 to 97 years of age, without diabetes by history or oral glucose tolerance test, was done between 1992 and 1996; plasma levels of intact insulin, proinsulin, and C-peptide were measured by radioimmunoassay. Based on questionnaire, medical history, or ECG abnormalities, 25% of men (n=136) and 24% of women (n=214) had prevalent CHD. All insulin variables were positively correlated with CHD risk factors. Compared with those without CHD, men and women with CHD had significantly higher levels of proinsulin. Women but not men with CHD also had higher levels of C-peptide and fasting and postchallenge insulin. Only proinsulin was significantly and independently associated with prevalent CHD in both men (OR=2.41, 1.42 to 4.11) and women (OR=1.80, 1.22 to 2.64) (adjusted for age, body mass index, systolic blood pressure, and HDL cholesterol). Similar analyses for fasting and postchallenge intact insulin and for C-peptide showed that among these three variables, only postchallenge insulin was significantly associated with CHD, and only in women.

Conclusions In older nondiabetic men and women, proinsulin was more strongly and consistently associated with CHD than was intact insulin.


Key Words: coronary disease • insulin • sex • diabetes mellitus




This article has been cited by other articles:


Home page
Diabetes CareHome page
D.-J. Kim and E. Barrett-Connor
Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the rancho bernardo study.
Diabetes Care, March 1, 2006; 29(3): 618 - 624.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Alssema, J. M. Dekker, G. Nijpels, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine
Proinsulin Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality: An 11-year follow-up of the Hoorn Study
Diabetes Care, April 1, 2005; 28(4): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto
Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. G. Araneta and E. Barrett-Connor
Subclinical Coronary Atherosclerosis in Asymptomatic Filipino and White Women
Circulation, November 2, 2004; 110(18): 2817 - 2823.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Haffner and A. J.G. Hanley
Do Increased Proinsulin Concentrations Explain the Excess Risk of Coronary Heart Disease in Diabetic and Prediabetic Subjects?
Circulation, April 30, 2002; 105(17): 2008 - 2009.
[Full Text] [PDF]